The latest oncology treatment & supportive care news
Treatment reduces breast cancer recurrence by 42% in patients with early-stage breast cancer with an inherited BRCA1 or BRCA2 gene abnormality
Results from the OlympiA clinical trial shows that olaparib reduces breast cancer recurrence by 42%…